Acceleron Pharma/ US00434H1086 /
2021-11-19 12:00:00 AM | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
178.7500USD | - | 7.88 mill. Turnover: - |
-Bid Size: - | -Ask Size: - | 179.8500 | 177.0600 |
GlobeNewswire
03-25
Aerovate Therapeutics Announces Full-Year 2023 Financial Results and Business Highlights
GlobeNewswire
2023-09-05
Xilio Therapeutics Announces Promotion of Katarina Luptakova, M.D., to Chief Medical Officer and Sco...
GlobeNewswire
2022-03-09
Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2021 Financia...
GlobeNewswire
2022-01-18
Krystal Biotech Appoints Jing Marantz, MD, PhD, MBA as Chief Business Officer and Rand Sutherland, M...
GlobeNewswire
2021-11-29
Proactive news headlines including Arovella Therapeutics, Jindalee Resources, Ironbark Zinc and Moho...
GlobeNewswire
2021-10-20
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates UMPQ, KOR, XLRN, VNE; Shareholders are Enco...
GlobeNewswire
2021-10-15
(XLRN): Johnson Fistel Investigates Proposed Sale of Acceleron Pharma; Is $180 a Fair Price?
GlobeNewswire
2021-10-11
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates DSPG, XLRN, GSKY, GWB; Shareholders are Enc...
GlobeNewswire
2021-10-06
Bragar Eagel & Squire, P.C. Announces that it Is Investigating the Boards of Directors of Home BancS...
GlobeNewswire
2021-10-06
Moore Kuehn Encourages NOTV, ARYD, XLRN, and TGP Investors to Contact Law Firm
GlobeNewswire
2021-10-04
Delix Therapeutics Named One of Fierce Biotech’s “Fierce 15” Companies of 2021
GlobeNewswire
2021-10-04
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates XLRN, ADTN, DSPG, KDMN; Shareholders are En...
GlobeNewswire
2021-10-01
ACCELERON PHARMA ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of XLRN and Encourages Investo...
GlobeNewswire
2021-09-30
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Acceleron Pharma Inc. Buyout
GlobeNewswire
2021-08-19
Solid Biosciences Announces Appointment of Michael Inbar, CPA, MBA, as Senior Vice President, Financ...
GlobeNewswire
2021-08-05
Pardes Biosciences Appoints Deborah M. Autor, J.D. and Laura J. Hamill to Board of Directors
GlobeNewswire
2021-03-04
Autolus Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Pro...
GlobeNewswire
2021-01-20
Imara Announces the Appointment of Kenneth Attie, M.D. as Chief Medical Officer
GlobeNewswire
2020-08-06
Autolus Therapeutics Reports Second Quarter 2020 Financial Results and Operational Progress